Methanol molecule hydrogen bonding

Methanol molecule hydrogen bonding scheme. Chemical infographic in volumetric style. Vector illustration with metallic molecules. Physics and Organic Chemistry educational concept.

Spotlight

Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic which completed a two-cohort phase 2 clinical trial and a small molecule imaging agent that has also completed a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra™, an ultra-orphan radiotherapy candidate currently in a phase 2 study under an SPA. Progenics’ first commercial product, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Ltd., a Valeant Pharmaceuticals International, Inc. company. For additional information, please.

Other Infographics
news image

An overview on crude oil and refineries

Infographic | February 3, 2020

Crude oil undergoes a process called fractional distillation in the refinery plants. Crude oil is being heaten to crack down to shorter hydrocarbon chain under different temperature. The major by products are refinery gas, petrol, naphtha, kerosene, diesel, lubricating oil, fuel oil and bitumen.

Read More
news image

One-Day Recycling Depot

Infographic | June 1, 2022

Foam packaging (white and coloured) such as foam containers for meat and produce, foam egg cartons, foam clamshells, cups and bowls for takeout food, firm foam cushion packaging to protect electronics, small appliances, etc.

Read More
news image

Global Petrochemical Market

Infographic | January 17, 2020

Global petrochemical market was valued at around USD 621.1 billion in 2018 and is expected to grow with a GAGS of over 8.0% during the forecast period 2019-2025. Increasing use of polymers In the packaging and automotive industries Extensive use of methanol in various end-use industries Increasing paints &coatings demand Easy aye/lability of raw material from the addle East.

Read More
news image

Multi-Functional Linings for Downstream Oil & Gas

Infographic | December 27, 2019

In Hydrocarbon storage there is a high likelihood of water contamination, this water gathers underneath the hydrocarbon cargo and can cause accelerated corrosion of the tank, requiring the lining of the base and 1 meter up the wall. For linings to perform as intended they need to have a chemical and mechanical bond to the substrate, which requires the steel to be clean, reactive and rough, often achieved through abrasive blasting.

Read More
news image

Working in heat can be hazardous and can cause harm to workers

Infographic | December 18, 2019

You must do everything reasonably practicable to eliminate the risks of working in heat. Where the risk cannot be eliminated, it must be minimised as much as reasonably practicable. Different workers may react differently to heat conditions. 5 Heat is not just a hazard when working outdoors on hot days. Consider the conditions inside your workplace and what hazards may be present.

Read More
news image

PROCESS SAFETY AND HOW IT REDUCES YOUR RISK

Infographic | February 26, 2020

An effective process safety program combines management and engineering efforts to help mitigate accidents and catastrophes involving hazardous materials. PROCESS SAFETY (PS) IS NOT JUST A RESPONSE TO REGULATORY NEEDS; IT SAVES LIVES AND FINANCIAL COSTS TO A BUSINESS

Read More

Spotlight

Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic which completed a two-cohort phase 2 clinical trial and a small molecule imaging agent that has also completed a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra™, an ultra-orphan radiotherapy candidate currently in a phase 2 study under an SPA. Progenics’ first commercial product, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Ltd., a Valeant Pharmaceuticals International, Inc. company. For additional information, please.

Events